Uso de análogo de GnRH após inseminação convencional e com protocolo de IATF em gado mestiço

• Autor(a) principal: Moura, Guilherme Silva
• Data de Publicação: 2008
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: LOCUS Repositório Institucional da UFV
• Texto Completo: http://locus.ufv.br/handle/123456789/5596
• topic: Bovino de corte; GnRH; IATF; Progesterona; Beef cattle; GnRH; FTAI; Progesterone; CNPQ::CIENCIAS AGRARIAS::ZOOTECNIA::PRODUCAO ANIMAL

The experiment was done with the following objectives: a) to evaluate the effect of GnRH administered at different times of the reproductive management on the pregnancy rate and serum P4 concentration; and b) to evaluate the effect of gonadotropins releasing hormone (GnRH) given twelve days after FTAI on serum levels of progesterone and above the rate of pregnancy. For the first objective 82 crossbred cows (Bos taurus indicus x Bos taurus Taurus) were allocated into three treatments: TControl (n = 28): the animals were observed for estrus detection and were inseminated after 8 to 12 hours; TGnRH0 (n = 27): similar to TControl plus the administration of 25 μg of GnRH at the AI time; and TGnRH12 (n = 27): similar to TControl plus the administration of 25 μg of GnRH at the AI time and also 12 days after AI. The pregnancy diagnostic was done on day 35 after the AI, by ultrasound scans through trans-rectal ultrasound. The pregnancy rate for TControl cows was 57.15% (16/28) for the first service, and for TGnRH0 and TGnRH12 cows, 63.00% (17/27) in each treatment. The protocol used did not affect the pregnancy rate of crossbred cows (P > 0.05). Also, there was no difference between the serum P4 concentrations between treatments, (P > 0.05). In conclusion, the administration of GnRH analogue, at the time of AI or 12 days after AI, did not improve the reproductive performance in crossbred cows. For the second objective 59 beef crossbred cows (Bos taurus indicus x Bos taurus taurus) were allocated into two treatments. TBE (n = 30): the day 0 - insertion of progesterone intravaginal device (Primer®) plus 2 mg of BE (Estrogin®), im; on 8, Remove the Primer® and applied 300 IU of eCG (Novormon ®) and 0.15 mg of PGF2 α (Prolise®), im, on 9, was applied 1 mg BE, im, and was do FTAI 48-56 hours after the withdrawal of PRIMER; and TBEGnRH12 (n = 29): the protocol was similar to TBE, but with administration of 25 μg of GnRH (Gestran Plus®, Lecirelin) twelve days after the FTAI. The pregnancy diagnostic was done on day 35 after the AI, by ultrasound scans through trans-rectal ultrasound. The pregnancy rate for TBE cows was 53.33% (16/30) for the first service, and for TBEGnRH12 cows, 37.93% (11/29). The protocol used did not affect the pregnancy rate of crossbred cows (P> 0.05). Also, there was no difference between the serum P4 concentrations between treatments (P> 0.05). In conclusion, the administration of the analogue of GnRH, lecirelina, at twelve days after the FTAI did not affect the pregnancy rates, neither affect the serum P4 concentration, between treatments, on days zero, five, 12 and 20 after the FTAI.